Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
05/2010
05/20/2010US20100125079 Biphenyl compounds useful as muscarinic receptor antagonists
05/20/2010US20100125078 Quinazoline derivatives as nk3 receptor antagonists
05/20/2010US20100125075 Antibacterial Agents
05/20/2010US20100125065 Carboline derivatives useful in the inhibition of angiogenesis
05/20/2010US20100125064 3-Imidazolyl-Indoles for the Treatment of Proliferative Diseases
05/20/2010US20100125062 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
05/20/2010US20100125061 Naphthylacetic acids
05/20/2010US20100125059 1-biarylazetidinone derivative
05/20/2010CA2743938A1 Substituted isoindoles as bace inhibitors and their use
05/20/2010CA2743902A1 Substituted dioxopiperidinyl phthalimide derivatives
05/20/2010CA2743558A1 Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof
05/20/2010CA2743537A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
05/20/2010CA2743531A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
05/20/2010CA2743483A1 Tetrasubstituted pyridazine hedgehog pathway antagonists
05/20/2010CA2743146A1 Heteroaryl diamide compounds useful as mmp-13 inhibitors
05/20/2010CA2743073A1 2,4-diaminopyrimidine derivates as ptk2- inhibitors for the treatment of abnormal cell growth
05/20/2010CA2742922A1 Novel pyrazolone-derivatives and their use as pd4 inhibitors
05/20/2010CA2742833A1 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
05/20/2010CA2742297A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
05/20/2010CA2740340A1 Pyridine derivative or its salt, pesticide containing it and process for its production
05/20/2010CA2739725A1 Naphthylacetic acids used as crth2 antagonists or partial agonists
05/20/2010CA2739040A1 Substituted (pyridyl)-azinylamine derivatives as plant protection agents
05/20/2010CA2739037A1 Fungicide heterocyclyl-triazinyl-amino derivatives
05/20/2010CA2738787A1 Substituted (pyridyl)-azinylamine derivatives as fungicides
05/20/2010CA2737932A1 Method for preparing a non-hydratable crystal form
05/20/2010CA2737587A1 Quinazoline derivatives as nk3 receptor antagonists
05/19/2010EP2186808A1 Salts of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
05/19/2010EP2186807A1 Process for the Preparation of Esomeprazole Magnesium Dihydrate
05/19/2010EP2186800A1 New mandelic acid derivatives and their use as thrombin inhibitors
05/19/2010EP2186516A1 Novel benzazepine derivative
05/19/2010EP2185548A1 Fungicide 2-pyridyl-methylene-thio carboxamide or 2-pyridyl-methylene-n-substituted carboximidamide derivatives
05/19/2010EP2185544A2 N-azacyclic substituted pyrrole, imidazole, triazole and tetrazole derivatives as agonists of the rup3 or gpr119 for the treatment of diabetes and metabolic disorders
05/19/2010EP2185543A2 Method for splitting omeprazole salts
05/19/2010EP2185542A2 Substituted quinoline derivatives as h1 receptor antagonists
05/19/2010EP2185541A1 Substituted phenylenediamines as inhibitors of the interaction between mdm2 and p53
05/19/2010EP2185540A1 Pyrrolidine aryl-ether as nk3 receptor antagonists
05/19/2010EP2185539A1 Viral polymerase inhibitors
05/19/2010EP2185538A2 Tetrahydropyridine carboxamide derivatives as trpvl antagonists
05/19/2010EP2185537A1 Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions
05/19/2010EP2185536A1 Herbicide triazolylpyridine ketones
05/19/2010EP2185524A1 Novel peptide inhibitors of hepatitis c virus replication
05/19/2010EP2185514A1 Vinyl-aryl derivatives for inflammation and immune-related uses
05/19/2010EP2185507A1 Fungicide n-6-membered fused (hetero)aryl-methylene-n-cycloalkyl carboxamide derivatives
05/19/2010EP2185506A1 Pyrrole compounds having sphingosine-1-phosphate receptor agonist or antagonist biological activity
05/19/2010EP2185502A1 Pyridinecarboxamide and benzamide derivatives as taar1 ligands
05/19/2010EP2184987A1 Bi-dentate compounds as kinase inhibitors
05/19/2010EP2184981A1 Pyridine carboxamide orexin receptor antagonists
05/19/2010EP1856059B1 Multimers of pyrimidinone derivatives and their use as human neutrophil elastase inhibitors
05/19/2010EP1706372B1 Alpha-hydroxy amides as bradykinin antagonists or inverse agonists
05/19/2010EP1599467B1 Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders
05/19/2010EP1558246B1 Proline derivatives having affinity for the calcium channel alpha-2-delta subunit
05/19/2010EP1371646B1 Aryl-substituted alicyclic compound and medical composition comprising the same
05/19/2010CN101711242A ((Bicylicheteroaryl) imidazolyl) methylheteroaryl compounds as adrenergic receptor agonists
05/19/2010CN101711241A PI 3-kinase inhibitors and methods of their use
05/18/2010US7718797 Fasudil-containing preparation and method of improving stability thereof
05/18/2010US7718796 hydrogenating (3S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)-2,3,4,7-tetrahydro-1H-azepin-3-ammonium salt in presence of cis-selective catalyst; calcitonin gene related peptide (CGRP)
05/18/2010US7718795 Succinoylamino benzodiazepines as inhibitors of aβ protein production
05/18/2010US7718706 pesticides and/or herbicides for controlling pests in crop protection, in the domestic sector, in the hygiene sector and in the protection of stored products
05/18/2010US7718691 3-Azabicyclo[3.1.0]hexane-amide derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus, AIDS, cytomegalovirus (CMV) and Epstein-Barr virus (EBV), liver disease such as alcoholism and primary biliar cirrhosis
05/18/2010US7718686 Gastrointestinal disorders; irritable bowel syndrome
05/18/2010US7718673 Heterocyclic amides such as beta-(((1-(4-((4,5-dihydro-1H-imidazol-2-yl)amino)-1-oxobutyl)-4 -piperidinyl)carbonyl)amino) -,(beta 3S)-3-quinolinepropanoic acid, used as antagonists for cellular adhesion molecules
05/18/2010US7718668 phosphodiesterase inhibitor; drug for respiratory system disorders
05/18/2010US7718655 formed via cyanuric chloride; for treatment of cancer and proliferative diseases
05/18/2010US7718650 Piperazino or diazepino-substituted arylsulfonamides; obesity, type II diabetes and/or central nervous system disorders; 4-chloro-N-[5-(4-methyl-1,4-diazepan-1-yl)-2-nitrophenyl]benzenesulfonamide for example; Serotonin 5-HT6 receptor antagonist activity
05/18/2010US7718576 Peroxide-based chemiluminescent assays and chemiluminescent compounds used therein
05/18/2010CA2616119C Method of preparing esomeprazole and salts thereof
05/18/2010CA2465247C Benzimidazoles and analogues and their use as protein kinases inhibitors
05/18/2010CA2438421C Process for the preparation of imidazole compounds
05/18/2010CA2422371C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2422367C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2338223C Viologen linked acridine based molecule and process for the preparation thereof
05/18/2010CA2304204C Quinoline-containing .alpha.-ketoamide cysteine and serine protease inhibitors
05/14/2010WO2010054398A1 Compounds useful as inhibitors of atr kinase
05/14/2010WO2010054032A2 Apparatus and method using rotary flow distribution mechanisms
05/14/2010WO2010053944A1 Improved method of making piperidine derivatives
05/14/2010WO2010053861A2 Biologically active amides
05/14/2010WO2010053732A1 Isoindoline compounds for use in the treatment of cancer
05/14/2010WO2010053583A2 Small molecule cd4 mimetics and uses thereof
05/14/2010WO2010053182A1 Kynurenine production inhibitor
05/14/2010WO2010053120A1 Carbamate compound or salt thereof
05/14/2010WO2010053068A1 Novel useful therapeutic agent for lower urinary tract symptom
05/14/2010WO2010052625A1 Pyrrolidines
05/14/2010WO2010052569A2 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
05/14/2010WO2010052448A2 Fused pyrazine derivatives as kinase inhibitors
05/14/2010WO2010052256A1 Melanocortin receptor antagonist compounds, process for preparing them and use thereof in human medicine and cosmetics
05/14/2010WO2010052255A1 Melanocortin receptor modulators, process for preparing them and use thereof in human medicine and cosmetics
05/14/2010WO2010052253A1 Oxoazetidine derivatives, process for the preparation thereof and use thereof in human medicine and in cosmetics
05/14/2010WO2010052199A1 Heterocyclic gamma secretase modulators
05/14/2010WO2010052198A1 ( pyrrolidin-2 -yl) phenyl derivatives for use in the treatment of pain
05/14/2010WO2010051977A1 Substituted disulfonamides as bri-modulators
05/14/2010WO2010019210A3 Halofuginone analogs for inhibition of trna synthetases and uses thereof
05/14/2010WO2010011868A3 Pyridine sulfonamide modulators of endothelin-a-receptor
05/14/2010WO2010005572A3 Alpha-keto heterocycles as faah inhibitors
05/14/2010WO2009156484A3 Organic compounds
05/14/2010WO2009066309A9 Process for preparation of omeprazole
05/14/2010CA2743196A1 Heterocyclic gamma secretase modulators
05/14/2010CA2743134A1 Compounds useful as inhibitors of atr kinase
05/14/2010CA2742744A1 Apparatus and method using rotary flow distribution mechanisms
05/14/2010CA2742741A1 Substituted disulfonamides
05/14/2010CA2742515A1 Modulators of cxcr7
1 ... 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 ... 1080